CytomX Therapeutics (CTMX) Net Margin (2014 - 2026)
CytomX Therapeutics (CTMX) posted Net Margin of -1457.40% for Q2 2026, down 1456.58 percentage points from -0.83% a year earlier and down 1279.51 percentage points from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Net Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at CytomX Therapeutics was -435.21%, down 469.22 percentage points year-over-year; for FY2025, it was -26.73%, down 49.81 percentage points from FY2024.
- Annual Net Margin shows a five-year change of +68.00 percentage points (FY2020 to FY2025).
- In prior years, CytomX Therapeutics' Net Margin was 23.08% in FY2024 (+23.64 pp), -0.56% in FY2023 (+186.25 pp), -186.82% in FY2022 (+123.73 pp) and -310.54% in FY2021 (-215.81 pp).
- Quarterly Net Margin has run from a low of -3998.49% in Q4 2025 to a high of 49.55% in Q4 2024 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last four quarters, with an average year-over-year change of -736.77 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q1 2023, with a gain of 339.68 percentage points; the weakest was Q4 2025, with a drop of 4048.04 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -177.89% (Q1 2026), -3998.49% (Q4 2025) and -238.62% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | -1,457.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,457.40% |
| Mar 31, 2026 | -177.89% |
| Dec 31, 2025 | -3,998.49% |
| Sep 30, 2025 | -238.62% |
| Jun 30, 2025 | -0.83% |
| Mar 31, 2025 | 46.20% |
| Dec 31, 2024 | 49.55% |
| Sep 30, 2024 | 17.16% |
| Jun 30, 2024 | -26.02% |
| Mar 31, 2024 | 33.26% |
| Dec 31, 2023 | 3.15% |
| Sep 30, 2023 | 11.34% |
| Jun 30, 2023 | -4.40% |
| Mar 31, 2023 | -14.09% |
| Dec 31, 2022 | -43.61% |
| Sep 30, 2022 | -260.73% |
| Jun 30, 2022 | -229.49% |
| Mar 31, 2022 | -353.77% |
| Dec 31, 2021 | -312.82% |
| Sep 30, 2021 | -337.16% |
API Access
CytomX Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();